Lack of any Association of the CTLA-4 +49 G/A Polymorphism with Breast Cancer Risk in a North Indian Population |
Minhas, Sachin
(Department of Medical Oncology, Sir Ganga Ram Hospital)
Bhalla, Sunita (Department of Pathology, Sir Ganga Ram Hospital) Shokeen, Yogender (Department of Medical Oncology, Sir Ganga Ram Hospital) Jauhri, Mayank (Department of Medical Oncology, Sir Ganga Ram Hospital) Saxena, Renu (Department of Medical Genetics, Sir Ganga Ram Hospital) Verma, Ishwar Chandra (Department of Medical Genetics, Sir Ganga Ram Hospital) Aggarwal, Shyam (Department of Medical Oncology, Sir Ganga Ram Hospital) |
1 | Zhang B, Beeghly-Fadiel A, Long J, et al (2011). Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Lancet Oncol, 12, 477-88. DOI ScienceOn |
2 | Takiar R, Nadayil D, Nandakumar A (2010). Projections of number of cancer cases in India (2010-2020) by cancer groups. Asian Pac J Cancer Prev, 11, 1045-9. |
3 | Sun T, Hu S, Shen H, et al (2009). Genetic polymorphisms in cytotoxic T-lymphocyte antigen 4 and cancer: the dialectical nature of subtle human immune dysregulation. Cancer Res, 69, 6011-4. |
4 | Ueda H, Howson JM, Esposito L, et al (2003). Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature, 423, 506-11 DOI ScienceOn |
5 | Wang L, Li D, Fu Z, et al (2007). Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population. BMC Cancer, 7, 173. DOI |
6 | Reiman JM, Kmieciak M, Manjili MH, et al (2007). Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol, 17, 275-87. DOI |
7 | Maurer M, Loserth S, Kolb-Maurer A, et al (2002). A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics, 54, 1-8. DOI |
8 | Monne M, Piras G, Palmas A, Arru L, et al (2004). Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma. Am J Hematol, 76, 14-8. DOI |
9 | Qi P, Ruan CP, Wang H, et al (2010). CTLA-4 +49A>G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese. Int J Colorectal Dis, 25, 39-45. DOI |
10 | Rodriguez S, Gaunt T R and Day I. N. M. (2009) Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol, 169, 505-14. |
11 | Shaukat U, Ismail M, Mehmood N (2013). Epidemiology, major risk factors and genetic predisposition for breast cancer in the Pakistani population. Asian Pac J Cancer Prev, 14, 5625-9. 과학기술학회마을 DOI |
12 | Solerio E, Tappero G, Iannace L, et al (2005). CTLA4 gene polymorphism in Italian patients with colorectal adenoma and cancer. Dig Liver Dis, 37, 170-5. DOI |
13 | Song B, Liu Y, Liu J, et al (2011). CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis. Respiration, 82, 439-44. DOI |
14 | Sun T, Zhou Y, Yang M, et al (2008). Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res, 68, 7025-34. DOI |
15 | Dilmec F, Ozgonul A, Uzunkoy A, et al (2008). Investigation of CTLA-4 and CD28 gene polymorphisms in a group of Turkish patients with colorectal cancer. Int J Immunogenet, 35, 317-21. DOI |
16 | Taheri NS, Bakhshandehnosrat S, Tabiei MN, et al (2012). Epidemiological pattern of breast cancer in Iranian women: is there an ethnic disparity? Asian Pac J Cancer Prev, 13, 4517-20. 과학기술학회마을 DOI ScienceOn |
17 | Geng R, Song F, Yang X, et al (2013). Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis. Tumour Biol. [Epub ahead of print] |
18 | Chistiakov DA, Savost'anov KV, Turakulov RI, et al (2006). Genetic analysis and functional evaluation of the C/T (-318) and A/G(-1661) polymorphisms of the CTLA-4 gene inpatients affected with Graves' disease. Clin Immunol, 118, 233-42. DOI |
19 | Feng M, Zhang FB, Deng HR. et al (2013). The CTLA4 +49A/G polymorphism is associated with an increased risk of Hashimoto's thyroiditis in Asian but not Caucasian populations: an updated meta-analysis. Endocrine, 44, 350-8. DOI |
20 | Ghaderi A. (2011). CTLA4 gene variants in autoimmunity and cancer: a comparative review. Iran J Immunol, 8, 127-49. |
21 | Ghaderi A, Yeganeh F, Kalantari T, et al (2004). Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res Treat, 86, 1-7. DOI |
22 | Hou R, Cao B, Chen Z, et al (2010). Association of cytotoxic T lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer. Mol Biol Rep, 37, 515-20. DOI |
23 | Blank CU (2014). The perspective of immunotherapy: new molecules and new mechanisms of action in immune modulation. Curr Opin Oncol, 26, 204-14 DOI |
24 | Ligers A, Teleshova N, Masterman T, et al (2001). CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun, 2, 145-52. DOI ScienceOn |
25 | Mandal RK, Mittal T, Kapoor R, et al (2010). NER and BER repair gene polymorphisms in a healthy north Indian cohort and comparison with different ethnic groups worldwide. Asian Pac J Cancer Prev, 11, 1601-4. |